Avidity Biosciences

OverviewSuggest Edit

Avidity Biosciences is a biotech company pioneering Antibody Oligonucleotide Conjugates (AOC). AOCs combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapeutics to overcome barriers to the delivery of oligonucleotides and target genetic drivers of disease.

TypePrivate
Founded2013
HQLa Jolla, US
Websiteaviditybiosciences.com

Latest Updates

Employees (est.) (Oct 2019)28(+12%)

Key People/Management at Avidity Biosciences

Tony Hsu

Tony Hsu

Founder and Chief Investment Officer at Alethea Capital Management, LLC

Avidity Biosciences Office Locations

Avidity Biosciences has an office in La Jolla
La Jolla, US (HQ)
10975 N Torrey Pines Rd #150
Show all (1)

Avidity Biosciences Financials and Metrics

Summary Metrics

Founding Date

2013

Avidity Biosciences total Funding

$31 m

Avidity Biosciences latest funding size

$15 m

Time since last funding

6 months ago

Avidity Biosciences investors

Avidity Biosciences's latest funding round in April 2019 was reported to be $15 m. In total, Avidity Biosciences has raised $31 m
Show all financial metrics

Avidity Biosciences Online and Social Media Presence

Embed Graph

Avidity Biosciences News and Updates

Avidity Biosciences Appoints Sarah Boyce as Chief Executive Officer

LA JOLLA, Calif., Oct. 1, 2019 /PRNewswire/ -- Avidity Biosciences, a privately-held biotechnology company pioneering Antibody Oligonucleotide Conjugates (AOCs™), announced today the appointment of global business leader Sarah Boyce as President and Chief Executive Officer and a member of...

Lilly and Avidity Biosciences Announce Licensing and Research Collaboration

INDIANAPOLIS and LA JOLLA, Calif., April 22, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Avidity Biosciences, Inc. today announced a global licensing and research collaboration focused on the discovery, development and commercialization of potential new medicines in...

Avidity Biosciences Blogs

Avidity Biosciences to Present at the 2019 Myotonic Annual Conference

La Jolla, California, September 12, 2019 (PRNEWSWIRE) – Avidity Biosciences, a privately-held biotechnology company pioneering Antibody Oligonucleotide Conjugates (AOCs™), today announced that Arthur A. Levin, Ph.D., Chief Scientific Officer, is scheduled to present at the 2019 Myotonic Annual Confe…

Avidity Biosciences Adds Drug Development Veterans Edward Kaye and Noreen Henig to Board of Directors

La Jolla, California, August 22, 2019 (PR NEWSWIRE) – Avidity Biosciences, a biotechnology company pioneering Antibody-Oligonucleotide Conjugates (AOCs™) focused in rare muscle disorders and other serious diseases, today announced the appointment of Noreen Henig, M.D. and Edward Kaye, M.D., to the c…

Avidity Biosciences Frequently Asked Questions

  • When was Avidity Biosciences founded?

    Avidity Biosciences was founded in 2013.

  • Who are Avidity Biosciences key executives?

    Avidity Biosciences's key executives are Tony Hsu.

  • How many employees does Avidity Biosciences have?

    Avidity Biosciences has 28 employees.

  • Who are Avidity Biosciences competitors?

    Competitors of Avidity Biosciences include U.S. Stem Cell, Cannabis Sativa and CEL-SCI.

  • Where is Avidity Biosciences headquarters?

    Avidity Biosciences headquarters is located at 10975 N Torrey Pines Rd #150, La Jolla.

  • Where are Avidity Biosciences offices?

    Avidity Biosciences has an office in La Jolla.

  • How many offices does Avidity Biosciences have?

    Avidity Biosciences has 1 office.